open access

Online first
Review paper
Published online: 2022-06-17
Get Citation

Mitral valve prolapse: From new mechanisms to diagnostic challenges

Idit Tessler12, Noga Reshef2, Shoshana Shpitzen1, Dan Gilon12, Ronen Durst12
DOI: 10.33963/KP.a2022.0147
·
Pubmed: 35724336
Affiliations
  1. Cardiology Department, Hadassah Medical Center, Jerusalem
  2. Faculty of Medicine, The Hebrew University, Jerusalem, Israel

open access

Online first
Review
Published online: 2022-06-17

Abstract

Mitral valve prolapse (MVP) is the most common primary valvular abnormality, associated with various degrees of incompetence and sequelae, including heart failure and sudden cardiac death. Recent improvements in echocardiographic techniques and new insights into mitral valve anatomy and physiology have rendered the diagnosis of this condition more accurate and reliable. Here we review the genetic etiology, clinical significance, diagnosis, and treatment options for MVP patients.

Abstract

Mitral valve prolapse (MVP) is the most common primary valvular abnormality, associated with various degrees of incompetence and sequelae, including heart failure and sudden cardiac death. Recent improvements in echocardiographic techniques and new insights into mitral valve anatomy and physiology have rendered the diagnosis of this condition more accurate and reliable. Here we review the genetic etiology, clinical significance, diagnosis, and treatment options for MVP patients.

Get Citation

Keywords

echocardiography, genetics, heart valve, mitral valve prolapse

About this article
Title

Mitral valve prolapse: From new mechanisms to diagnostic challenges

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Review paper

Published online

2022-06-17

Page views

148

Article views/downloads

60

DOI

10.33963/KP.a2022.0147

Pubmed

35724336

Keywords

echocardiography
genetics
heart valve
mitral valve prolapse

Authors

Idit Tessler
Noga Reshef
Shoshana Shpitzen
Dan Gilon
Ronen Durst

References (37)
  1. Cuffer M, Barbillion M. Nouvelles recherches sur le bruit de galop cardiaque [article in French]. Arch Gen Med. ; 1887: 19.
  2. Barlow JB, Pocock WA, Marchand P, et al. The significance of late systolic murmurs. Am Heart J. 1963; 66(4): 443–452.
  3. Muthukumar L, Jahangir A, Jan MF, et al. Association between malignant mitral valve prolapse and sudden cardiac death: A review. JAMA Cardiol. 2020; 5(9): 1053–1061.
  4. Hjortnaes J, Keegan J, Bruneval P, et al. Comparative histopathological analysis of mitral valves in barlow disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg. 2016; 28(4): 757–767.
  5. Levine R, Stathogiannis E, Newell J, et al. Reconsideration of echocardiographic standards for mitral valve prolapse: Lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 1988; 11(5): 1010–1019.
  6. Levine RA, Triulzi MO, Harrigan P, et al. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 1987; 75(4): 756–767.
  7. Malcolm AD. Mitral valve prolapse associated with other disorders. Casual coincidence, common link, or fundamental genetic disturbance? Br Heart J. 1985; 53(4): 353–362.
  8. Kyndt F, Gueffet JP, Probst V, et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation. 2007; 115(1): 40–49.
  9. Devereux RB, Kramer-Fox R, Brown WT, et al. Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse. J Am Coll Cardiol. 1986; 8(4): 763–772.
  10. Strahan NV, Murphy EA, Fortuin NJ, et al. Inheritance of the mitral valve prolapse syndrome. Discussion of a three-dimensional penetrance model. Am J Med. 1983; 74(6): 967–972.
  11. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999; 65(5): 1242–1251.
  12. Freed LA, Acierno JS, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003; 72(6): 1551–1559.
  13. Le Tourneau T, Le Scouarnec S, Cueff C, et al. New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study. Eur Heart J. 2018; 39(15): 1269–1277.
  14. Durst R, Sauls K, Peal DS, et al. Mutations in DCHS1 cause mitral valve prolapse. Nature. 2015; 525(7567): 109–113.
  15. Toomer KA, Yu M, Fulmer D, et al. Primary cilia defects causing mitral valve prolapse. Sci Transl Med. 2019; 11(493).
  16. Roselli C, Yu M, Nauffal V, et al. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse. Eur Heart J. 2022; 43(17): 1668–1680.
  17. Nappi F, Iervolino A, Avtaar Singh SS, et al. MicroRNAs in valvular heart diseases: Biological regulators, prognostic markers and therapeutical targets. Int J Mol Sci. 2021; 22(22).
  18. Bui AnH, Roujol S, Foppa M, et al. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart. 2017; 103(3): 204–209.
  19. Hickey AJ, Wilcken DE. Age and the clinical profile of idiopathic mitral valve prolapse. Br Heart J. 1986; 55(6): 582–586.
  20. Düren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol. 1988; 11(1): 42–47.
  21. Iung B, Baron G, Tornos P, et al. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007; 32(11): 609–661.
  22. Nishimura RA, McGoon MD. Perspectives on mitral-valve prolapse. N Engl J Med. 1999; 341(1): 48–50.
  23. Alenazy A, Eltayeb A, Alotaibi MK, et al. Diagnosis of mitral valve prolapse: much more than simple prolapse. Multimodality approach to risk stratification and therapeutic management. J Clin Med. 2022; 11(2).
  24. Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015; 132(7): 556–566.
  25. Essayagh B, Sabbag A, Benfari G, et al. Presentation and outcome of arrhythmic mitral valve prolapse. J Am Coll Cardiol. 2020; 76(6): 637–649.
  26. Maron BJ, Rowin EJ, Maron MS. Paradigm of sudden death prevention in hypertrophic cardiomyopathy. Circ Res. 2019; 125(4): 370–378.
  27. Maron BJ, Haas TS, Ahluwalia A, et al. Demographics and epidemiology of sudden deaths in young competitive athletes: from the United States national registry. Am J Med. 2016; 129(11): 1170–1177.
  28. Reinier K, Chugh SS. Sudden death associated with mitral valve prolapse. JACC: Clinical Electrophysiology. 2021; 7(8): 1035–1037.
  29. Bennett S, Thamman R, Griffiths T, et al. Mitral annular disjunction: A systematic review of the literature. Echocardiography. 2019; 36(8): 1549–1558.
  30. Muthukumar L, Rahman F, Jan MF, et al. The pickelhaube sign: novel echocardiographic risk marker for malignant mitral valve prolapse syndrome. JACC Cardiovasc Imaging. 2017; 10(9): 1078–1080.
  31. Trochu JN, Le Tourneau T, Obadia JF, et al. Economic burden of functional and organic mitral valve regurgitation. Arch Cardiovasc Dis. 2015; 108(2): 88–96.
  32. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999; 341(1): 1–7.
  33. Gilon D, Buonanno FS, Joffe MM, et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med. 1999; 341(1): 8–13.
  34. Musella F, Azzu A, Antonopoulos AS, et al. Comprehensive mitral valve prolapse assessment by cardiovascular MRI. Clin Radiol. 2022; 77(2): e120–e129.
  35. Wibawa K, Ivan I, Jessica G, et al. The outcome of ventricular arrhythmias associated with mitral valve prolapse after catheter ablation: a systematic review and meta-analysis. Cureus. 2021; 13(12): e20310.
  36. Judge DP, Rouf R, Habashi J, et al. Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res. 2011; 4(6): 741–747.
  37. Ng C, Cheng A, Myers L, et al. TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004; 114(11): 1586–1592.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl